ADVERTISEMENT
  About the SA Blog Network

Posts Tagged "University of Minnesota"

Molecules to Medicine

UMN: How many deaths have occurred during your clinical trials?

Angel of Grief

This series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide in 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues of [...]

Keep reading »
Molecules to Medicine

UMN agrees to outside review of clinical research practices—but what parts and by whom?

Delivering petition to Gov. Dayton's office-Photo by Jeff Baillon, Fox 9 News

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues [...]

Keep reading »
Molecules to Medicine

A Clinical Trial and Suicide: What do the UMN and Disney Have in Common?

Disneys Cinderella castle by Childzy-Wikimedia

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues [...]

Keep reading »
Molecules to Medicine

uBiome: Ethical Lapse or Not?

uBiome’s CEO, Jessica Richman, seems to me to be a great saleswoman who also excels at sounding innocent and playing the misunderstood victim in the ethical controversy surrounding her company. I think this was well illustrated in her recent guest blog in Scientific American with Dr. Zachary Apte, co-founder and Chief Scientific Officer of uBiome. [...]

Keep reading »
Molecules to Medicine

Minnesota Attorney General Confirms They Did Not Exonerate UMN in Markingson Death

Dan and his mom, Mary Weiss

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues [...]

Keep reading »
Molecules to Medicine

Anti-Psychiatry Prejudice? A response to Dr. Lieberman

Facets of the field

  Kelly Hills (@rocza) was kind enough to call my attention to the guest post on SciAmMind by Jeffrey Lieberman, incoming president of the American Psychiatric Association (APA).   Frankly, I’m appalled by Lieberman’s post, especially as it was invited. Although masquerading as a reasoned critique, it is anything but that. Rather, the piece is [...]

Keep reading »
Molecules to Medicine

The s**t hits the fan – FDA, INDs, and fecal microbiota transplants

Bristol Stool Chart

This weekend, the proverbial s**t hit the fan over the Food & Drug Administration’s (FDA) decision to require an Investigational New Drug (IND) application for stool transplants—formally known as “fecal microbiota transplants (FMT)”—for the treatment of C. difficile colitis. “C. diff,” as it is known, is a severe inflammation of the bowel complicating treatment of [...]

Keep reading »
Molecules to Medicine

How Not to Run an Op-Ed Page

Editorial control

  On Mother’s Day, May 12, ethics Professor Carl Elliott had an Op-Ed published by the Minneapolis Star Tribune, “The University of Minnesota Research Case Needs Scrutiny.”   The Star Tribune began to post comments, the first being: Minnesoda73 May. 12, 13 6:10 PM The University of Minnesota has investigated itself and found itself innocent. [...]

Keep reading »
Molecules to Medicine

Yahrzeit – Reflections on Dan Markingson’s Legacy

Angel of Grief

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues [...]

Keep reading »
Molecules to Medicine

A New University of Minnesota Mystery-The Curious Departure of Mark Rotenberg

All that is necessary for the triumph of evil is that good men do nothing. -Edmund Burke One month ago, Mike Howard, family friend of Dan Markingson, who committed suicide while participating in a clinical trial at the UMN, launched a petition requesting that Governor Mark Dayton launch an independent investigation of research misconduct in [...]

Keep reading »

More from Scientific American

Scientific American Back To School

Back to School Sale!

12 Digital Issues + 4 Years of Archive Access just $19.99

Order Now >

X

Email this Article



This function is currently unavailable

X